Cytek Biosciences COO Resigns, Signaling Leadership Changes
PremiumCompany AnnouncementsCytek Biosciences COO Resigns, Signaling Leadership Changes
2M ago
Cytek Biosciences price target lowered to $8 from $8.50 at Piper Sandler
Premium
The Fly
Cytek Biosciences price target lowered to $8 from $8.50 at Piper Sandler
3M ago
Cytek Biosciences narrows FY24 revenue view to $203M-$210M, consensus $208.8M
Premium
The Fly
Cytek Biosciences narrows FY24 revenue view to $203M-$210M, consensus $208.8M
3M ago
Cytek Biosciences price target lowered to $8.50 from $10 at Piper Sandler
PremiumThe FlyCytek Biosciences price target lowered to $8.50 from $10 at Piper Sandler
6M ago
Cytek Biosciences backs FY24 revenue view $203M-$213M, consensus $207.89M
Premium
The Fly
Cytek Biosciences backs FY24 revenue view $203M-$213M, consensus $207.89M
6M ago
Cytek Biosciences reports Q1 EPS (5c), consensus (4c)
Premium
The Fly
Cytek Biosciences reports Q1 EPS (5c), consensus (4c)
6M ago
Cytek Biosciences sees FY24 revenue $203M-$213M, consensus $207.1M
PremiumThe FlyCytek Biosciences sees FY24 revenue $203M-$213M, consensus $207.1M
8M ago
Cytek Biosciences reports Q4 adjusted EBITDA $11.0M vs. $6.6M last year
Premium
The Fly
Cytek Biosciences reports Q4 adjusted EBITDA $11.0M vs. $6.6M last year
8M ago
Cytek Biosciences Enhances Executive Severance Benefit Plan
Premium
Company Announcements
Cytek Biosciences Enhances Executive Severance Benefit Plan
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100